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ABSTRACT 16 
Background: The effectiveness of transversus abdominis plane (TAP) blocks for acute pain 17 
relief after caesarean section, in comparison to normal practice, remains uncertain. 18 
Methods: Electronic literature databases were searched from inception to May 2016 for 19 
randomised controlled trials that assessed the effectiveness of TAP blocks following 20 
caesarean section. Trials were eligible if comparisons were made against no block or placebo, 21 
and/or intrathecal morphine. Risk of bias was assessed using the Cochrane tool. Data for 22 
consistent outcomes were subject, where possible, to meta-analysis and presented as either 23 
mean differences with 95% confidence intervals or incidence of a particular event. 24 
Results: Twenty published studies fulfilled our inclusion criteria. TAP blocks significantly 25 
reduced pain at rest both when compared with placebo or no TAP blocks (-0.96, 95% CI -1.67 26 
to -0.25, P=0.008) and intrathecal morphine (1.10, 95% CI 0.59 to 1.60, P<0.0001). Both 27 
these comparisons showed the greatest improvement with pain on movement, (-1.58, 95% CI 28 
-2.69 to -0.47, P=0.005 and 1.35, 95% CI 0.76 to 1.94, respectively, P<0.00001). Morphine 29 
consumption was significantly reduced with TAP blocks when compared to placebo or no 30 
TAP blocks (-15.88, 95% CI -22.02 to -9.73, P<0.00001). This significance was lost when 31 
TAP blocks were both compared to intrathecal morphine (0.89, 95% CI -0.64 to 2.43, P=0.25) 32 
and given in co-administration (0.00, 95% CI -0.10 to 0.10, P=1.00). 33 
Conclusion: TAP blocks provide effective analgesia after caesarean section; however, 34 
additional benefits are more difficult to demonstrate when long-acting intrathecal opioids are 35 
administered. 36 
 37 
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 39 
Introduction 40 
Acute pain from an abdominal incision can complicate birth by caesarean section (CS). 41 
Failure to achieve adequate pain control is one of the most common reasons for poor 42 
satisfaction among women who give birth by CS.
1
 Caesarean section is a common surgical 43 
procedure, with an increasing prevalence. Approximately 166 000 CS are performed annually 44 
in England alone (data for 2014/2015).
2
 Adequate postoperative analgesia hastens 45 
postoperative mobilisation, decreases maternal morbidity and facilitates bonding with the 46 
newborn.
3
 Neuraxial opioids can provide effective pain relief for many hours after surgery, 47 
although their administration has a well-defined risk of side effects including nausea, pruritus, 48 
urinary retention and potential for delayed respiratory depression.
4
 Alternative modalities of 49 
pain relief offer the prospect of a beneficial reduction in the side effect profile with no loss in 50 
analgesic efficacy.
1
 51 
The last two decades have seen peripheral nerve blockade gain prominence in the 52 
prevention and treatment of acute postoperative pain. The success of ultrasound-guided 53 
peripheral nerve localisation with nerve stimulation has fuelled new innovation in block 54 
technique and indication. These novel blocks can be performed with minimal risk of 55 
complications.
5, 6
 Tranversus abdominis plane (TAP) block’s mechanism of action requires 56 
anaesthesia to the sensory nerve supply of the anterior abdominal wall.
6-8
 Blockade of sensory 57 
nerves is achieved in the neurofascial plane between the internal oblique and transversus 58 
abdominis muscles through a well-defined entrance at the triangle of Petit.
7, 8
 
 
The use of TAP 59 
blocks to alleviate pain after non-obstetric abdominal surgery has become established.
9
 60 
However, evidence from recently published clinical trials has shown encouraging results that 61 
suggest that TAP blocks are effective for treating postoperative pain following CS. This 62 
systematic review and meta-analysis collated data from all published randomised controlled 63 
trials of TAP blocks to assess its effectiveness in reducing patient-reported postoperative pain 64 
scores and reducing opioid use following CS. 65 
 66 
Methods 67 
The systematic review was based on a prospective protocol designed using widely 68 
recommended methods and reported to PRISMA (Preferred Reporting Items for Systematic 69 
Reviews and Meta-Analyses) guidelines.
10-12
 No institutional review board approval was 70 
needed for this review. 71 
A comprehensive literature search strategy was used to search the following 72 
bibliographic databases, Embase, Medline and the Cochrane Library (CENTRAL), from 73 
database inception to May 2016. We adapted the search strategy used in a previous Cochrane 74 
review,
9
 by replacing search terms pertaining to abdominal surgery with variations for CS as 75 
MeSH terms or text. The Clinical Trials registers found at www.clinicaltrials.gov, 76 
www.isrctn.com and the World Health Organisation (WHO) International Clinical Trials 77 
Research Platform (ICTRP) were searched to identify ongoing trials. The authors of these 78 
trials were contacted via email to ask if they would be willing to contribute unpublished data. 79 
Bibliographies of all relevant primary articles and reviews were hand searched to identify 80 
articles missed by the electronic searches. A comprehensive database was constructed using 81 
Reference Manager 12.0 (Thomson Reuters) to store all identified references. No language 82 
restrictions were applied. 83 
Studies eligible for inclusion were selected in a two-step process. First, citations 84 
identified by the electronic database searches were screened. Full manuscripts were obtained 85 
for those citations that met, or potentially met, predetermined inclusion criteria. Two 86 
reviewers then independently inspected the manuscripts to confirm that they fulfilled the 87 
following criteria: 88 
1. Population: Women undergoing elective caesarean section 89 
2. Interventions: TAP blocks using any local anaesthetic agent, alone or in addition to 90 
intrathecal morphine (ITM). 91 
3. Comparator: No or placebo TAP blocks, alone or in addition to ITM. Studies comparing 92 
different doses of local anaesthetic in TAP blocks were excluded unless there was a 93 
control group. 94 
4. Outcomes: Pain scores (at rest and movement), opioid consumption, complications 95 
(nausea, vomiting, pruritus) and maternal satisfaction. 96 
5. Study design: Randomized controlled trial (RCT) where the action of TAP block could 97 
be assessed independently of any ITM administered. 98 
We extracted data on study characteristics, methods and results on to a pre-designed pro-99 
forma in duplicate. 100 
All manuscripts selected for inclusion were assessed using the risk of bias tool 101 
developed by the Cochrane Collaboration.
9
 A study was considered to be of high quality if it 102 
provided evidence of adequate randomisation sequence generation and allocation 103 
concealment, if blinding was used, if there were minimal missing outcome data or it was 104 
adequately addressed, and if the published paper was free of selective reporting and free of 105 
other biases. 106 
If a trial comparing various doses of TAP blocks was amongst those trials thought to 107 
be eligible for inclusion, every attempt was made to include these data. However, in these 108 
circumstances, a form of data manipulation was necessary before the data were used. A 109 
validated and recognized formula used by the Cochrane Collaboration enabled us to combine 110 
data from the various dosage arms and compare these against the placebo/control arm. 111 
Trials were grouped according to the question they addressed: a) the effectiveness of 112 
TAP blocks in the absence of ITM; b) comparison of ITM against TAP blocks; and c) the 113 
addition of TAP blocks to ITM. Where trials addressed more than two questions, the 114 
appropriate groups’ data were included in each comparison. No further subdivision of 115 
questions by technique, local anaesthetic used or dose was undertaken. 116 
 117 
Statistical analysis 118 
Outcome data were extracted from all included studies, as number of women, means and 119 
standard deviations for continuous variables and as proportions for dichotomous outcomes. If 120 
data were provided in another format, the author of the trial was contacted to ask if they could 121 
provide raw data. Failing this, every attempt was made to convert these values to allow the 122 
greatest amount of data to be combined. Outcome data were used to generate forest plots. 123 
Pain scores presented as a visual analogue scale (VAS) score were standardized to a 0–10 124 
point continuous scale. Where a VAS score was presented as median and interquartile range 125 
(IQR) and the group size was >20, these were assumed to follow a normal distribution, with 126 
the median assumed to be the mean and standard deviation=IQR/1.35. Data transformed in 127 
this way were added to meta-analyses in a secondary sensitivity analyses. Cumulative opioid 128 
consumption was considered, with opioid drugs other than morphine converted to morphine 129 
equivalent doses, using a published equivalence formula.
13
 
 
Incidence of postoperative nausea 130 
and vomiting (PONV) was variously reported as one entity, or as separate conditions. In the 131 
latter case, we used nausea data to avoid double counting. Pruritus was also measured in a 132 
variety of ways. Where possible, data were collapsed into a dichotomous measure of present 133 
or absent. All statistical analyses were performed in Review Manager 5.1 (Copenhagen: The 134 
Nordic Cochrane Centre, The Cochrane Collaboration 2011). Heterogeneity was described by 135 
the I
2
 statistic and where significant, a random effects model was used to produce the 136 
summary estimate. 137 
 138 
Results 139 
A total of 187 citations were identified through the electronic literature database searches. Of 140 
these, 146 were excluded after screening of titles and abstracts. A further 21 citations were 141 
discarded upon closer inspection, being either duplicate publications, not using a study design 142 
of interest (letters, reviews etc.), or not using a relevant intervention. The remaining 20 143 
articles were included in the systematic review (Fig. 1).
14-33 
Three abstracts were included in 144 
the systematic review,
19,31,32
 and we obtained unpublished data from one author.
32
 A search of 145 
the Clinical Trials register identified six relevant ongoing trials. However, none of these trials 146 
were at a suitable stage to contribute unpublished data.  147 
Table 1 provides a summary of the characteristics of the included published trials in 148 
addition to a breakdown of the quality criteria per trial. A table describing the ongoing studies 149 
is presented in Appendix A. Eleven trials evaluated the efficacy of TAP blocks versus placebo 150 
TAP blocks 
14-17, 19-22, 30, 31,33
  and three against no TAP blocks (only standard care),
18, 23, 29
 all 151 
of these in the absence of ITM. Kagwa et al. randomised patients to TAP blocks or ‘sham’ 152 
TAP blocks. Sham blocks involved pressing a transducer with a needleless syringe over each 153 
flank. We consider this to be equivalent to ‘No TAP blocks’.31 Three trials directly compared 154 
ITM with TAP blocks by employing ITM plus placebo TAP blocks in one group and 155 
intrathecal placebo and TAP blocks in the other,
22, 24, 25
 and five trials evaluated the addition 156 
of TAP blocks to ITM via the use of a placebo TAP injection.
22, 26-28, 32
 The trial by 157 
McMorrow et al. undertook all three comparisons. The trial by Puddy et al. reported 158 
comparisons with intrathecal diamorphine and was excluded from the meta-analysis since the 159 
analgesic profile of intrathecal diamorphine is substantially different to ITM, particularly in 160 
duration of action and side effects. These trials were retained in the systematic review. 161 
Sixteen of the 20 trials involved women undergoing an elective CS,
17-29, 31, 32,33
  with the 162 
remainder not specifying the nature of the CS. Trials involving emergency CS only were 163 
excluded since these  women may have laboured before CS, and would be more likely to have 164 
had the CS performed under epidural anaesthesia and may have a substantially different 165 
postoperative pain experience. There was an intention to perform bilateral TAP block in all 166 
trials, although this was not explicitly stated by Kagwa et al.
31
 An ultrasound-guided 167 
technique was used in 15 studies. 
14-17, 21, 23-28, 30-33
 and four trials used the anatomical 168 
landmark technique 
18, 20, 22, 29
  whilst in the final study, the approach was unclear.
19
 169 
Bupivacaine was the local anaesthetic of choice in eight trials 
14, 16, 18, 22, 24, 32, 29, 31
 
 
170 
whilst nine trials used ropivacaine; 
15, 20, 21, 25-28, 30,33
  three others used levobupivacaine.
17, 19, 23
 
 
171 
Eighteen trials performed CS under spinal (or combined spinal-epidural) anaesthesia, 
14-17, 19-
172 
22, 24-32,33
 while general anaesthesia was used in two trials.
18, 23
 173 
A varied mix of supplementary postoperative analgesia regimens was used. Pain 174 
scores were reported in all included trials; however, it was not possible to use data from every 175 
trial due to inconsistencies in the way data were presented or pain symptoms described. 176 
Where the primary outcome was explicitly stated, the most frequently employed was 177 
morphine consumption (or equivalent), being specified by nine trials.
14, 15, 17, 20, 23, 25, 29, 30, 33
 
 
178 
Other commonly measured outcomes included, pain scores at rest, 
18, 31
 pain on movement, 
22, 
179 
26-28, 31
 wound hyperalgesia 
16
 and time to first analgesic request.
24, 32
 McKeen et al. chose to 180 
have four primary outcomes, pain at rest, pain on movement, quality of recovery and 181 
cumulative opioid consumption.
21
 
 
The abstract by Hoydonckx et al did not provide details of 182 
the primary outcome.
19
  183 
A detailed breakdown of the quality of the trials is given in Table 1. The majority 184 
provided adequate information to assess quality criteria. Two studies were only available in 185 
abstract format and attempts to contact the corresponding authors for further information were 186 
unsuccessful.
19,31
 Strict, random group allocation concealment was a feature of 13 studies, 187 
whilst 19 were blinded. Only 10 trials provided a satisfactory level of detail to show that their 188 
trial was free of attrition and other biases. We would have expected all women to have been 189 
followed up for the primary outcome, irrespective of protocol compliance, but whether this 190 
was done was unclear in seven studies. There were inherent blinding complications in the four 191 
trials that compared TAP blocks to no TAP blocks, but these trials have indicated that 192 
investigators and patients were blinded to treatment allocation.
18, 23, 29, 31
 
 
Patients in the no 193 
treatment groups in the Eslamian et al.
18
 Kagwa et al.
31
 and Tan et al.
23
 trials received no 194 
injections; therefore the skin was not punctured. Tan was able to blind patients by placing a 195 
pressure dressing over the site where the TAP block would have been injected.
23
 This is 196 
similar to treatment of patients in the control arm of the Srivastava et al trial,
29
 who did not 197 
receive a block, but they still had their skin punctured on both sides by palpating the triangle 198 
of Petit. Patients in this trial, had pressure dressings applied to their abdominal wounds that 199 
covered the skin puncture sites.
29
  200 
While pain at rest, pain on movement and morphine consumption remain our three 201 
main outcomes, data on other outcomes, including PONV and pruritus have been tabulated in 202 
Table 2. There were statistically significant reductions in the incidence of PONV at 24 h 203 
amongst both the TAP blocks versus control (OR 0.53, 95% CI 0.29 to 0.97, P=0.04), and the 204 
TAP blocks versus ITM comparisons (OR 0.24, 95% CI 0.09 to 0.64, P=0.004). Both these 205 
findings in favour of the TAP blocks arm, were based on data from seven trials (n=354) and 206 
two trials (n=106), respectively. Occurrence and severity of pruritus were significantly 207 
increased in those receiving ITM with TAP blocks (OR 2.63, 95% CI 1.16 to 5.95, P=0.02).
22, 
208 
26, 27
 Forest plots have been generated for these outcomes but are displayed in Appendix B. 209 
 210 
1. Pain at rest 211 
TAP blocks versus control (or no treatment) 212 
Nine out of the 14 trials that compared TAP blocks with a control provided disaggregated 213 
data on pain at rest.
14, 16-18, 20-23, 29
 
 
whereas pain scores could not be disaggregated in one 214 
trial,
15
 
 
and the abstracts by Hoydonckx et al.
19
 and Kagwa et al.
31
 did not provide useable 215 
data. Sriramka et al. reported overall VAS scores rather than pain scores specific to pain at 216 
rest and/or movement.
30
 They reported that patients randomised to TAP blocks had lower pain 217 
scores on a VAS (median 26 vs. 47mm, P=0.008). Attempts to contact the author for 218 
unpublished data were unsuccessful. Mankikar et al. also reported overall pain scores, in the 219 
form of a figure. We were unable to accurately measure individual scores. Attempts to contact 220 
the author for numerical data were unsuccessful.
33
  Pooled results for pain at rest 6 h 221 
postoperatively favoured TAP blocks (mean difference -1.43, 95% CI -2.82 to -0.04, P=0.04). 222 
However, this significance disappeared by 24 h (mean difference -0.63, 95% CI -1.38 to 0.11, 223 
P=0.10) (Fig. 2). Overall results, combining both time points indicate that TAP blocks, when 224 
compared to control, are effective for pain at rest (mean difference -0.96, 95% CI -1.67 to -225 
0.25, P=0.008). 226 
 227 
ITM versus TAP blocks 228 
Results from the two trials with clearly reported data
22, 25
 
 
showed significant effect in favour 229 
of ITM when TAP blocks and ITM were measured at 6 h (mean difference 1.17, 95% CI 0.46 230 
to 1.87, P=0.001) this significance continued at 24 h postoperatively (mean difference 1.03, 231 
95% CI 0.31 to 1.74, P=0.005) (Fig. 3). Overall results support these findings (mean 232 
difference 1.10, 95% CI 0.59 to 1.60, P<0.0001). Data from the trial by Kanazi et al. could 233 
not be included in the forest plot as it was non-normally distributed and it considered both 234 
somatic and visceral pain at 2 and 4 h postoperatively.
24
 Pain scores at rest were not 235 
significantly different at 6 and 24 h. 236 
 237 
ITM with or without TAP blocks 238 
Five trials provided data which were used to produce the forest plot in Fig. 4.
22, 26-28, 32
 
 
239 
Although Puddy et al. provided data, this was not included in the meta-analysis as their 240 
comparison involved diamorphine. Therefore, based on data from the remaining four trials, 241 
short-term results suggest that a combination of ITM and TAP blocks are more effective than 242 
ITM alone in the 6h after surgery (mean difference -0.50, 95% CI -0.92 to -0.08, P=0.02); 243 
however, this effect is not sustained at 24 h (mean difference 0.12, 95% CI -0.33 to 0.58, 244 
P=0.60). Combining data over both time points suggest no effect (mean difference -0.21, 95% 245 
CI -0.52 to 0.10, P=0.18). 246 
 247 
2. Pain on movement 248 
TAP blocks versus control (or no treatment) 249 
Nine trials provided data for these meta-analyses.
14, 16-18, 20-23, 29
 
 
TAP blocks were no more 250 
effective than control for treating pain on movement 6 h postoperatively (mean difference -251 
1.65, 95% CI -3.52 to 0.22, P=0.08) (Fig. 5). At 24 h, a statistically significant effect was seen 252 
in favour of TAP blocks (mean difference -1.54, 95% CI -3.02 to -0.05, P=0.04). Combining 253 
data from both time points for an overall effect followed this significant trend (mean 254 
difference -1.58, 95% CI -2.69 to -0.47, P=0.005). Abstracts by Hoydonckx et al.
19
 and 255 
Kagwa et al.
31
 did not contain useable data. Other trials unable to contribute data were Belavy 256 
et al.,
15
 Sriramka et al.
30
 and Mankikar et al.
33
  who reported overall pain scores, rather than 257 
differentiating between pain at rest and on movement. 258 
 259 
ITM versus TAP blocks 260 
As with pain at rest, data for this outcome were only available in a usable form in two trials.
22, 
261 
25
 Pooled results from these trials found a statistically significant effect in favour of ITM for 262 
alleviating pain on movement at both 6 h (mean difference 1.36, 95% CI 0.51 to 2.21, 263 
P=0.002), and 24 h (mean difference 1.34, 95% CI 0.51 to 2.17, P=0.002) (Fig. 6). Overall 264 
pooled results using both time points, corroborate this finding (mean difference 1.35, 95% CI 265 
0.76 to 1.94, P=0.00001). 266 
 267 
ITM with or without TAP blocks 268 
All five trials included in this comparison provided data for this outcome. 
 
However, it was 269 
only possible to use data from four trials, after the exclusion of data from Puddy et al.
22, 26-28
 270 
A statistically significant effect was seen at 6 h, which showed that a combination of both 271 
ITM and TAP blocks were more effective than ITM alone (mean difference -0.89, 95% CI -272 
1.47 to -0.31, P=0.002) (Fig. 7). This effect, however, could not be detected at 24 h (mean 273 
difference 0.28, 95% CI -0.27 to 0.82, P=0.32). The overall pooled effect was not statistically 274 
significant (mean difference -0.27, 95% CI -0.67 to 0.12, P=0.18).  275 
 276 
3. Morphine consumption 277 
TAP blocks versus control (or no treatment) 278 
Three trials each provided morphine consumption data at 2, 6 and 12 h postoperatively and 279 
seven at 24 h.
14, 15, 17, 20, 21, 23, 33
  Pooled data at all four time points found a statistically 280 
significant lower morphine consumption in the TAP blocks group (Fig. 8): 2 h (mean 281 
difference 3.23mg, 95% CI -5.37 to -1.09, P=0.003); 6 h (mean difference 12.27mg, 95% CI -282 
13.76 to -10.77, P<0.00001); 12 h (mean difference 19.86mg, 95% CI -27.33 to -12.39, 283 
P<0.00001); and 24 h (mean difference 21.27mg, 95% CI -32.18 to -10.36, P=0.0001). 284 
Overall pooled results across all time points, follow a similar trend (mean difference 15.88mg, 285 
95% CI -22.02 to -9.73, P<0.00001). Seven trials were unable to contribute data. Bollag et 286 
al.,
16
 McMorrow et al.,
22
 Sriramka et al.
30
 and Srivastava et al.
29
 presented the time points as 287 
ranges rather than at single time-points. Therefore, we were unable to combine this with the 288 
cumulative data. Eslamian et al. provided data in a format that did not allow for merging with 289 
other data.
18
 The abstracts by Hoydonckx et al and Kagwa et al did not provide data.
19
 
31
 290 
 291 
ITM versus TAP blocks 292 
Of the three trials reporting morphine or morphine equivalent dosage, only data from Loane et 293 
al.
25
 were useable, therefore a forest plot is not provided. They reported no difference in 294 
morphine consumption between the groups at 0–2 h (mean difference 0.70 mg, 95% CI -1.59 295 
to 0.20, P=0.13), 2–6 h (mean difference 0.62 mg, 95% CI -0.87 to 2.11, P=0.42) and 6–10 h 296 
(mean difference 0.85 mg, 95% CI -0.33 to 2.03, P=0.16).
25
 However, this difference became 297 
statistically significant between 10–24 h, with lower use in the ITM group, (mean difference 298 
4.80 mg, 95% CI 1.76 to 7.84, P=0.002). Both McMorrow et al.
22
 and Kanazai et al.
24
 noted a 299 
statistically significant difference in morphine or equivalent opioid consumption between 6–300 
12 h but at no other time points. These two trials provided cumulative data, so were not 301 
combined with data from Loane et al.
25
 302 
 303 
ITM with or without TAP blocks 304 
A forest plot was unsuitable for this comparison and outcome as only Costello et al provided 305 
data.
26
 They showed that morphine consumption remained unaffected at both 24 h (mean 306 
difference 0.00mg, 95% CI -0.30 to 0.30, P=1.00) and 48 h (mean difference 0.00mg, 95% CI 307 
-0.10 to 0.10, P=1.00).
26
 McMorrow et al.
22
 did not observe a difference in morphine 308 
consumption at any time point, reporting a median consumption of 5 mg and 6 mg in the ITM 309 
and TAP blocks, and ITM and placebo TAP blocks, respectively, at 24 h. Data from Lee et 310 
al.
27
 and Singh et al.
28
 were not in a compatible format and therefore were not included. Data 311 
provided by Puddy et al again could not contribute to the meta-analysis.
32
 312 
 313 
4. Maternal Satisfaction 314 
Due to variation in how satisfaction with analgesia was captured and reported, no meta- 315 
analyses were attempted and results are explained narratively. 316 
 317 
TAP block versus control (or no treatment) 318 
Satisfaction was measured in a variety of ways but was higher for TAP blocks than controls in 319 
6 RCTs,
14, 15, 22, 23, 17, 29
 although only statistically significant in four studies,
14, 15, 23, 29
 whilst 320 
there was less satisfaction within TAP blocks in one study.
21 
The remaining seven studies 321 
either did not measure or report satisfaction with analgesia. 322 
 323 
ITM versus TAP blocks 324 
Kanazi et al.
24
 presented satisfaction data on a three-point scale: highly satisfied, satisfied and 325 
dissatisfied. In the ITM and placebo TAP blocks group 26 of 28 women were either satisfied 326 
or highly satisfied, compared to 22 of 29 women in the intrathecal placebo and TAP blocks 327 
group. McMorrow et al.
22
 reported a non-significantly higher median satisfaction score in the 328 
ITM and placebo TAP blocks group at all time points. Satisfaction was not measured by 329 
Loane et al.
25
 330 
 331 
ITM with or without TAP block 332 
Plotting of data from two trials found no overall statistically significant difference between 333 
the two groups.
26, 28
 Like other comparisons, there was no statistically significant difference 334 
between groups in the McMorrow et al trial.
22
 Lee et al
27
 reported more patients were satisfied 335 
with TAP blocks given in conjunction with ITM rather than placebo TAP blocks and ITM. 336 
However, these values were not statistically significant at 24 and 48 h. Puddy et al did not 337 
report satisfaction as an outcome.
32
 338 
 339 
Discussion 340 
The evidence generated by this meta-analysis demonstrates that TAP blocks are an effective 341 
intervention in providing acute pain relief after CS. Whilst they may not confer much 342 
additional analgesia when intrathecal opioids are used; they are at least as effective. Our 343 
findings support the premise that TAP blocks could offer particular advantages in the context 344 
of general anaesthesia for CS when the only alternative is systemic opioid analgesia. 345 
The greatest analgesic effect was seen in women given TAP blocks in the absence of 346 
ITM. Pooled results found that TAP blocks were more effective than control at alleviating 347 
pain at rest, which was reduced by a clinically meaningful 3.5 points out of 10,
 34
although this 348 
effect was diminished by 24 h. Intrathecal morphine was no more beneficial than TAP blocks 349 
for pain at rest. When TAP blocks and ITM were combined, the effect was superior in the 350 
short term to ITM alone, but again this effect was not sustained at 24 h. TAP blocks were 351 
more effective in alleviating pain on movement compared to control. However, when TAP 352 
blocks were compared to ITM, this effect was lost. This was also the case when TAP blocks 353 
and ITM were compared to ITM alone. 354 
TAP blocks alone, when compared to control, were again the most effective modality, 355 
in reducing postoperative opioid consumption, in this case reducing consumption by more 356 
than half. However, when compared to ITM, this short-term benefit was lost. There was no 357 
difference between TAP blocks and ITM at 2, 6 and 10 h postoperatively. However, ITM was 358 
superior to TAP blocks at 24 h. When the two were combined, and compared against ITM, no 359 
difference was found. These findings support the premise that TAP blocks offer particular 360 
advantages when spinal opioids are not administered. 361 
TAP blocks were superior in reducing the incidence of PONV when compared to ITM 362 
but not when compared to control. This effect must be taken in the context of any differences 363 
in opioid consumption. A combination of TAP blocks and ITM, was no more effective than 364 
ITM alone, suggesting that the administration of neuraxial morphine is the most potent arbiter 365 
of the prevalence of PONV after CS. 366 
No evidence of differential rates of pruritus were observed between women receiving 367 
TAP blocks, ITM or control, whilst the addition of TAP blocks to ITM increased the rate of 368 
pruritus. There was considerable variation in the pooled rates of pruritus in the TAP blocks 369 
group from 30-62%, and those only receiving ITM, in the three comparisons, making it 370 
imprudent to rank the groups for this adverse event. 371 
More women were satisfied with TAP blocks than control. However, when TAP 372 
blocks were compared with ITM, a greater number of women preferred ITM. When these two 373 
treatment options were combined, no difference in satisfaction was found. Whilst maternal 374 
satisfaction with childbirth is increasingly recognised as a vital aspect of care, maternal 375 
satisfaction with planned CS is very high and any effect of the addition of TAP blocks may be 376 
difficult to detect. 377 
The strength of our review lies in the systematic methodology with which trials were 378 
identified and their quality appraised. Risk of bias was assessed using widely accepted 379 
Cochrane collaboration tools. The quality of included trials in general was good. The 380 
inclusion of three trials only available as abstracts 
19
 
, 31, 32
almost certainly contributed to 381 
worsening the overall impression of quality of the included trials.  382 
A further strength is that we have tried to reflect clinical practice as much as possible. 383 
Although intrathecal diamorphine is widely used in UK practice, the single trial using 384 
diamorphine in their intervention arm was excluded from analysis. This was justifiable since 385 
ITM and diamorphine are quite distinct in their pharmacology, effectiveness and duration of 386 
action. The side effect profiles of the two agents also differ substantially. Diamorphine is not 387 
clinically available in USA or mainland Europe. In this sense, UK practice is unusual. It is 388 
hoped that by retaining this study in the systematic review, our findings are relevant to as 389 
wide an audience as possible.  390 
Several sources of heterogeneity were identified. Despite a certain degree of 391 
standardisation amongst the population (most patients were undergoing an elective CS), the 392 
intervention was a source of heterogeneity. All trials fell into two broad groups, those that 393 
used ultrasound-guided techniques and those that used anatomical landmark techniques. 394 
Further sources of heterogeneity were the postoperative analgesia regimens, which varied 395 
considerably. The local anaesthetic agent used to perform TAP blocks was not standard 396 
amongst the trials. The choice and dose of the local anaesthetic was much more varied. Once 397 
trials had been separated into their comparisons, further separation according to type of local 398 
anaesthetic agent used would not have been possible with the limited number of trials 399 
available. Further heterogeneity was mitigated, by keeping methods of data synthesis 400 
consistent; for example conversion of tramadol consumption data to morphine consumption. 401 
We tried to incorporate heterogeneity by using a random effects model where appropriate, 402 
rather than stepwise exclusion of outliers, again due to the small number of studies.  403 
Due to variations in how PONV outcomes were measured, we made the following 404 
assumption, in order to be able to combine as much data as possible. Some trials provided 405 
PONV data, which was a combined score of nausea and vomiting, others described separate 406 
scores. For these trials, we used nausea data alone, since using data for both nausea and 407 
vomiting would risk some patients being double-counted.  408 
As our review and others have highlighted, TAP blocks are an effective analgesic 409 
intervention for acute pain following CS. Our meta-analysis also generates further compelling 410 
evidence for the effectiveness of intrathecal opioids in providing pain relief after CS. Our 411 
analysis does not support the assertion that TAP blocks replace the need for intrathecal opioid 412 
analgesia, thereby reducing the incidence of spinal-opioid-related side effects, nor favour a 413 
widespread change in practice. Nonetheless, TAP blocks offer particular advantages in the 414 
context of CS where neuraxial opioids are not utilised. 415 
The results of our review are supported by those found by other systematic 416 
reviews.
35,36
  Abdallah et al found that TAP blocks were more effective than placebo for 417 
providing analgesia.
35
  They were also superior at reducing the need for morphine in the first 418 
24 h after surgery, based on an analgesic regimen that excluded ITM. Mishriky et al. 419 
corroborated these findings.
36
 This review included a third comparator, ITM and reported that 420 
postoperative analgesia was significantly improved by TAP blocks in women who had not 421 
received ITM. However, this benefit was lost in women who had received ITM. Improved 422 
analgesia was seen with ITM, compared to TAP blocks alone. A further narrative review, by 423 
Sharkey et al.
37
 reinforced this sentiment which was convergent in opinion with the Mishriky 424 
review.
36 
Our results are broadly convergent with the other evidence synthesis in the field. 425 
Fusco et al. found that TAP blocks reduced both opioid consumption and opioid related side 426 
effects. There were also improvements in postoperative pain and patient satisfaction with 427 
TAP blocks.
38
 Reviews by Ripolles et al.
39
 and Baeriswyl et al.
40
 are broader systematic 428 
reviews, focussing on all types of abdominal surgery, including CS. These reviews confirmed 429 
the analgesic efficacy provided by TAP blocks.  430 
While certain parallels can be drawn between our review and those by Abdallah and 431 
Mishriky, our review provides a more comprehensive and accurate picture of the current 432 
evidence by encompassing all relevant trials up to the present day. This includes those found 433 
by Abdallah and Mishriky but also identifying trials published after their search date. Our 434 
review acts as a summation of other relevant reviews. While the reviews by Abdallah and 435 
Mishriky consisted of sample sizes of 312 and 524, respectively, the current review involves 436 
data from 1293 women. 437 
This review has highlighted gaps in the evidence, which could be subjected to future 438 
study. Caesarean section is a common intervention, which is becoming more prevalent. 439 
Therefore, research in this area is pertinent to a large population. The potential benefit of TAP 440 
blocks over a control for post-CS analgesia, in the absence of ITM, is supported by several 441 
trials. Future research should focus on assessing the effectiveness of ITM compared to and in 442 
addition to TAP blocks. Larger, well designed, adequately powered trials are needed to 443 
achieve this. Three local anaesthetic agents were used in the trials included in this review, 444 
with bupivacaine being the most common. As our results have shown, combining TAP blocks 445 
and ITM has beneficial outcomes particularly for pain at rest. Assessing whether lower doses 446 
of this treatment option has implications for improved analgesia and reduction of opioid-447 
induced side effects is also another area worth pursuing. 448 
The findings of our review have shown that TAP blocks are most effective in relieving 449 
postoperative pain following a CS delivery, in patients who have not received ITM. There is 450 
much more uncertainty surrounding the use of TAP blocks instead of ITM or in addition to it. 451 
Future trials should consider this an area for exploration.  452 
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reference list.  470 
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throughout 472 
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